RANI
Rani Therapeutics Holdings, Inc.Company with tickers: RANI
CIK
1856725
CUSIP
753018100
Shares Outstanding
99,912,515
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,708,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $10,047,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Research & Development | $5,161,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-8,339,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-7,033,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | $-0.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |